Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
Status:
Completed
Trial end date:
2019-05-09
Target enrollment:
Participant gender:
Summary
To evaluate the single-dose bioequivalence of oral suspension and intravenous (IV)
formulation of edaravone in the fasting state in healthy adult subjects